Twitter

Archive for July 6th, 2012


GnRHa Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation

Condition :   Infertile High-risk Patients With Polycystic Ovaries Intervention :   Drug: a drug withdrawal during the long protocol Sponsors :   Nanjing University;   Nanjing University Recruiting – verified July 2012

Read More...

A Study of MPDL3280A in Combination With Avastin (Bevacizumab) or With Avastin Plus Chemotherapy in Patients With Advanced Solid Tumors

Condition :   Neoplasms Interventions :   Drug: MPDL3280A;   Drug: bevacizumab [Avastin];   Drug: chemotherapy;   Drug: MPDL3280A;   Drug: bevacizumab [Avastin] Sponsors :   Genentech;   Genentech Recruiting – verified July 2012

Read More...

Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients

Condition :   Castration-resistant Prostate Cancer Interventions :   Drug: BEZ235;   Drug: BKM120;   Drug: BEZ235;   Drug: BKM120 Sponsors :   Novartis;   Novartis Pharmaceuticals Not yet recruiting – verified July 2012

Read More...

A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma

Condition :   Stage II and III Rectal Adenocarcinoma Interventions :   Radiation: Radiation Therapy;   Drug: Bavituximab;   Drug: Capecitabine Sponsors :   University of Texas Southwestern Medical Center;   University of Texas Southwestern Medical Center Not yet recruiting – verified June 2012

Read More...

External Drainage Versus Internal Drainage of Pancreatic Duct With a Stent After Pancreaticoduodenectomy (EDIDPD)

Conditions :   Postoperative Pancreatic Fistula (POPF);   Surgical Complications Intervention :   Procedure: Internal Drainage of Pancreatic Duct after pancreactomy Sponsors :   Tianjin Medical University Cancer Institute and Hospital;   Tianjin Medical University Cancer Institute and Hospital Recruiting – verified June 2012

Read More...

Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

Conditions :   Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Non-Hodgkin Lymphoma;   Hodgkin Lymphoma;   Chronic Lymphocytic Leukemia;   Multiple Myeloma;   Myelodysplastic Syndrome Intervention :   Biological: iTreg Sponsors :   Masonic Cancer Center, University of Minnesota;   Masonic Cancer Center, University of Minnesota Not yet recruiting – verified July 2012

Read More...

Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening

Condition :   Colorectal Cancer Interventions :   Behavioral: 1 FIT kit;   Behavioral: 2 FIT kit Sponsors :   Kaiser Permanente;   Kaiser Permanente;   National Cancer Institute (NCI) Not yet recruiting – verified July 2012

Read More...

A Study to Assess the Pharmacokinetics of Ramucirumab in Combination With FOLFIRI

Condition :   Solid Tumors Interventions :   Biological: Ramucirumab;   Drug: Irinotecan;   Drug: Folinic acid;   Drug: 5-Fluorouracil Sponsors :   ImClone LLC;   ImClone LLC Not yet recruiting – verified July 2012

Read More...

Study of Safety and Preliminary Efficacy for LDK378 in Japanese Patients With Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)

Condition :   Tumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK) Intervention :   Drug: LDK378 Sponsors :   Novartis;   Novartis Pharmaceuticals Not yet recruiting – verified July 2012

Read More...

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

Condition :   Cervical Intraepithelial Neoplasia Grade 3 Intervention :   Genetic: GX-188 administered by electroporation Sponsors :   Genexine Co., Ltd.;   Genexine Co., Ltd. Not yet recruiting – verified July 2012

Read More...